• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CARRA:儿童关节炎和风湿病研究联盟。

CARRA: The Childhood Arthritis and Rheumatology Research Alliance.

机构信息

Children's Hospital Colorado, University of Colorado, 13123 E. 16th Ave., Rheumatology B-311, Aurora, CO 80045, USA.

Duke University Medical Center, Pediatric Rheumatology, Box 3212 Med Ctr, Durham, NC 27710, USA.

出版信息

Rheum Dis Clin North Am. 2021 Nov;47(4):531-543. doi: 10.1016/j.rdc.2021.07.010. Epub 2021 Sep 2.

DOI:10.1016/j.rdc.2021.07.010
PMID:34635290
Abstract

The Childhood Arthritis & Rheumatology Research Alliance (CARRA) launched in 2000 as a small network of pediatric rheumatologists and investigators dedicated to promoting collaborative research to improve the care and outcomes of childhood-onset rheumatic diseases. Over the past 2 decades, CARRA has grown to become a major driver of advances in evidence-based medicine and career development in pediatric rheumatology. Its research approach has transformed pediatric rheumatology. CARRA is a vibrant organization that will continue to facilitate impactful research in the care of children, adolescents, and young adults with rheumatic disease in the years to come.

摘要

儿童关节炎和风湿病研究联盟(CARRA)于 2000 年成立,最初是一个由儿科风湿病学家和研究人员组成的小型网络,致力于促进合作研究,以改善儿童发病的风湿性疾病的治疗效果和预后。在过去的 20 年里,CARRA 已经发展成为推动循证医学进步和儿科风湿病学职业发展的主要力量。其研究方法改变了儿科风湿病学。CARRA 是一个充满活力的组织,在未来的几年里,它将继续促进对患有风湿性疾病的儿童、青少年和年轻人的护理产生重大影响的研究。

相似文献

1
CARRA: The Childhood Arthritis and Rheumatology Research Alliance.CARRA:儿童关节炎和风湿病研究联盟。
Rheum Dis Clin North Am. 2021 Nov;47(4):531-543. doi: 10.1016/j.rdc.2021.07.010. Epub 2021 Sep 2.
2
Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).系统性幼年特发性关节炎初始治疗四种共识治疗方案的贝叶斯比较有效性研究:系统性幼年特发性关节炎治疗的一线选择(FROST)
Clin Trials. 2018 Jun;15(3):268-277. doi: 10.1177/1740774518761367. Epub 2018 Mar 15.
3
The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases.儿童关节炎和风湿病研究联盟共识治疗计划:走向儿科风湿病的比较疗效。
Arthritis Rheumatol. 2018 May;70(5):669-678. doi: 10.1002/art.40395. Epub 2018 Mar 31.
4
Proceedings of the 2024 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting.
Pediatr Rheumatol Online J. 2024 Sep 13;22(Suppl 1):81. doi: 10.1186/s12969-024-00998-w.
5
The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.新的儿童关节炎与风湿病研究联盟(CARRA)登记处:前12个月登记患者的设计、原理及特征
Pediatr Rheumatol Online J. 2017 Apr 17;15(1):30. doi: 10.1186/s12969-017-0160-6.
6
Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.比较儿童关节炎与风湿病研究联盟(CARRA)系统性幼年特发性关节炎共识治疗方案的初步研究。
Pediatr Rheumatol Online J. 2017 Apr 11;15(1):23. doi: 10.1186/s12969-017-0157-1.
7
Patient-Reported Outcomes Among Transition-Age Young Adults With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.儿童关节炎与风湿病研究联盟注册中心中患有幼年特发性关节炎的过渡年龄青年成人的患者报告结局
J Rheumatol. 2023 Jan;50(1):98-106. doi: 10.3899/jrheum.220514. Epub 2022 Sep 15.
8
Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis.儿童关节炎和风湿病研究联盟新发病多关节型幼年特发性关节炎的共识治疗方案。
Arthritis Care Res (Hoboken). 2014 Jul;66(7):1063-72. doi: 10.1002/acr.22259.
9
Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry.新儿童关节炎和风湿病研究联盟注册研究中纳入的幼年特发性肌炎患儿的基线特征。
Pediatr Rheumatol Online J. 2022 Jul 19;20(1):50. doi: 10.1186/s12969-022-00709-3.
10
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.难治性幼年皮肌炎的生物疗法:北美儿童关节炎与风湿病研究联盟的五年经验
Pediatr Rheumatol Online J. 2017 Jun 13;15(1):50. doi: 10.1186/s12969-017-0174-0.

引用本文的文献

1
Biorepositories For Global Rare Disease Research: A Narrative Review.用于全球罕见病研究的生物样本库:一项叙述性综述
Curr Rheumatol Rep. 2025 May 21;27(1):24. doi: 10.1007/s11926-025-01189-6.
2
American College of Rheumatology Guidance Statements for Addressing Mental Health Concerns in Youth With Pediatric Rheumatologic Diseases.美国风湿病学会关于解决患有小儿风湿性疾病青少年心理健康问题的指导声明。
Arthritis Care Res (Hoboken). 2025 Aug;77(8):953-964. doi: 10.1002/acr.25519. Epub 2025 May 5.
3
Association Between Early Immunosuppression Center Variability and One-Year Outcomes After Pediatric Liver Transplant.
儿童肝移植后早期免疫抑制中心变异性与一年期预后之间的关联
Pediatr Transplant. 2025 Feb;29(1):e70018. doi: 10.1111/petr.70018.
4
Associations Between Patient-Reported Outcome Measures of Physical and Psychological Functioning and Willingness to Share Social Media Data for Research Among Adolescents With a Chronic Rheumatic Disease: Cross-Sectional Survey.慢性风湿性疾病青少年患者报告的身体和心理功能结局测量与愿意分享社交媒体数据用于研究之间的关联:横断面调查
JMIR Pediatr Parent. 2023 Dec 6;6:e46555. doi: 10.2196/46555.
5
Insurance Status and Tumor Necrosis Factor Inhibitor Initiation Among Children With Juvenile Idiopathic Arthritis in the CARRA Registry.保险状况与儿童类风湿关节炎患者肿瘤坏死因子抑制剂的使用:CARRA 注册研究
J Rheumatol. 2023 Aug;50(8):1047-1057. doi: 10.3899/jrheum.220871. Epub 2022 Dec 15.
6
Data silos are undermining drug development and failing rare disease patients.数据孤岛正在破坏药物研发,使罕见病患者的处境雪上加霜。
Orphanet J Rare Dis. 2021 Apr 7;16(1):161. doi: 10.1186/s13023-021-01806-4.